BofA upgraded Zimmer Biomet to Neutral from Underperform with a $160 price target.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ZBH:
- Zimmer Biomet price target raised to $150 from $130 at Canaccord
- Zimmer Biomet price target raised to $156 from $141 at RBC Capital
- Zimmer Biomet price target raised to $160 from $144 at Raymond James
- Zimmer Biomet price target raised to $172 from $145 at Baird
- Zimmer Biomet price target raised to $160 from $145 at JMP Securities